Inflammation
The body's coordinated response to injury, infection, or irritation. Acute inflammation is short-lived and supports healing. Chronic inflammation persists and is implicated in cardiovascular disease, metabolic disease, autoimmunity, and post-viral syndromes.
How researchers study it
The molecular basis of inflammation involves pattern-recognition receptors on innate immune cells, cytokine cascades (IL-1, IL-6, TNF-alpha), recruitment of neutrophils and macrophages, complement activation, and tissue remodeling. Resolution requires specialized pro-resolving mediators (resolvins, lipoxins, protectins). When resolution fails, inflammation becomes chronic (Furman D et al., Nature Medicine, 2019).
Researchers measure inflammation with serum biomarkers — high-sensitivity C-reactive protein (hsCRP), interleukin-6, fibrinogen, ferritin. None is perfect; each captures a slice. Imaging (PET, MRI) can localize inflammation in specific tissues. Chronic low-grade inflammation has been associated with cardiovascular disease, insulin resistance, neurodegenerative disease, and aging in large prospective cohorts.
In COVID-19, inflammation features prominently both in the acute phase (where cytokine elevations correlate with severity) and in long COVID (where some patients show persistent elevation of inflammatory markers and immune-cell activation, though not uniformly). The NIH's health information portal and CDC publish overviews. The 2019 Nature Medicine review by Furman and colleagues is a useful primer on chronic inflammation across diseases (PubMed 31806905).
Common misconceptions
- Furman D et al. "Chronic inflammation in the etiology of disease across the life span." Nature Medicine, 2019. PubMed: 31806905
- NIH Health Information. nih.gov/health-information
- CDC. cdc.gov